140 related articles for article (PubMed ID: 22746226)
21. The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics.
Dunn AG; Bourgeois FT; Murthy S; Mandl KD; Day RO; Coiera E
Clin Pharmacol Ther; 2012 Apr; 91(4):685-91. PubMed ID: 22378152
[TBL] [Abstract][Full Text] [Related]
22. Overview of best practices in conducting comparative-effectiveness reviews.
Guise JM; Viswanathan M
Clin Pharmacol Ther; 2011 Dec; 90(6):876-82. PubMed ID: 22048219
[TBL] [Abstract][Full Text] [Related]
23. [Complaints and quality of neurosurgery].
Hanoa R
Tidsskr Nor Laegeforen; 2003 Feb; 123(4):443. PubMed ID: 12643052
[No Abstract] [Full Text] [Related]
24. [Toward a comparative effectiveness policy in Italy].
Perucci CA
Epidemiol Prev; 2011; 35(2):77-9. PubMed ID: 21628748
[No Abstract] [Full Text] [Related]
25. Decision analysis and cost-effectiveness analysis for comparative effectiveness research--a primer.
Sher DJ; Punglia RS
Semin Radiat Oncol; 2014 Jan; 24(1):14-24. PubMed ID: 24314338
[TBL] [Abstract][Full Text] [Related]
26. A regulator's view of comparative effectiveness research.
Temple R
Clin Trials; 2012 Feb; 9(1):56-65. PubMed ID: 21975523
[TBL] [Abstract][Full Text] [Related]
27. Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.
Alemayehu D; Cappelleri JC
J Eval Clin Pract; 2013 Aug; 19(4):579-83. PubMed ID: 22128798
[TBL] [Abstract][Full Text] [Related]
28. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
Stein J
N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
[No Abstract] [Full Text] [Related]
29. Con: comparative effectiveness research. More than dollars and cents.
Krishnan JA
Am J Respir Crit Care Med; 2011 Apr; 183(8):975-6. PubMed ID: 21498823
[No Abstract] [Full Text] [Related]
30. Comments on 'Comparative effectiveness research: Policy context, methods development and research infrastructure'.
Morton SC
Stat Med; 2010 Aug; 29(19):1989-90; discussion 1996-7. PubMed ID: 20683889
[No Abstract] [Full Text] [Related]
31. [Neurosurgery in Russian Federation].
Krylov VV; Konovalov AN; Dash'yan VG; Kon-Dakov EN; Tanyashin SV; Gorelyshev SK; Dreval' ON; Grin' AA; Parfenov VE; Kushniruk PI; Gulyaev DA; Kolotvinov VS; Rzaev DA; Poshataev KE; Kravets LY; Mozheiko RA; Kas'yanov VA; Kordonsky AY; Trifonov IS; Kalandari AA; Shatokhin TA; Airapetyan AA; Dalibaldyan VA; Grigor'ev IV; Sytnik AV
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(1):5-12. PubMed ID: 28291209
[No Abstract] [Full Text] [Related]
32. Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.
Pickard AS; Lee TA; Solem CT; Joo MJ; Schumock GT; Krishnan JA
Clin Pharmacol Ther; 2011 Dec; 90(6):888-92. PubMed ID: 22048220
[TBL] [Abstract][Full Text] [Related]
33. Role of comparative effectiveness research in cancer funding decisions in Ontario, Canada.
Hoch JS; Hodgson DC; Earle CC
J Clin Oncol; 2012 Dec; 30(34):4262-6. PubMed ID: 23071242
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness research in oncology: the promise, challenges, and opportunities.
Chen RC
Semin Radiat Oncol; 2014 Jan; 24(1):1-4. PubMed ID: 24314336
[No Abstract] [Full Text] [Related]
35. Meta-analysis of diagnostic test accuracy in neurosurgical practice.
Dubourg J; Berhouma M; Cotton M; Messerer M
Neurosurg Focus; 2012 Jul; 33(1):E5. PubMed ID: 22746237
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness research in radiation oncology: assessing technology.
Chen AB
Semin Radiat Oncol; 2014 Jan; 24(1):25-34. PubMed ID: 24314339
[TBL] [Abstract][Full Text] [Related]
37. Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research.
Girman CJ; Faries D; Ryan P; Rotelli M; Belger M; Binkowitz B; O'Neill R;
J Comp Eff Res; 2014 May; 3(3):259-70. PubMed ID: 24969153
[TBL] [Abstract][Full Text] [Related]
38. Panel discussion 2.
Ellenberg S; Luce B; Fleming T; Siegel J; Strom B; Hernán M; Temple R; Sackett D; Bourguignon C; Bekelman J; Berry D; Rotelli M; Judkins D; Schwartz S; Goodman S
Clin Trials; 2012 Feb; 9(1):66-79. PubMed ID: 22334467
[No Abstract] [Full Text] [Related]
39. The case for a comparative, value-based alternative to the patient-centered outcomes research model for comparative effectiveness research.
Marko NF; Weil RJ
Neurosurg Focus; 2012 Jul; 33(1):E8. PubMed ID: 22746240
[TBL] [Abstract][Full Text] [Related]
40. Reengineering acute episodic and chronic care delivery: the Geisinger Health System experience.
Slotkin JR; Casale AS; Steele GD; Toms SA
Neurosurg Focus; 2012 Jul; 33(1):E16. PubMed ID: 22746233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
